INSIGHTS ON QUALITY ASSURANCE

• Pharmaceutical Bioburden And Microbial Limits Testing

  Explore how membrane filtration tools streamline bioburden and microbial enumeration while improving ergonomics and easing routine tasks in fast‑paced pharmaceutical microbiology labs.

• Why Emerging Drug Developers Can't Afford To Delay Analytical Development

  Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.

• Aggregate Analysis Of Semaglutide

  Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

• The Impact Of The FDA's New CSA Draft Guideline

  Ensure product quality and patient safety by examining the FDA's draft guideline on Computer Software Assurance that emphasizes a risk-based approach to streamline software validation.

• The Role Of CAPA In Pharma

  10/17/2024

  Establishing a robust, risk-based CAPA system prevents recurring process deviations, satisfies ICH Q10 guidelines, and ensures standing inspection readiness.

• Enhanced Flow Kit Performance With Leak And PUPSIT Testing

  1/13/2026

  Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.

• Aseptic Filling Quality Through Precision

  3/20/2026

  Precise measurement shapes every reliable workcell. Meet Andrew, a specialist who verifies components with micron‑level accuracy, ensuring each piece is built to perform exactly as designed.

• Choosing The Best mRNA Manufacturing Strategy

  12/12/2025

  Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.

• The mRNA Journey: From Design To LNP-Ready Molecules For Research

  11/25/2025

  Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.